The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer
Clinical trial NCT01732276 · UNKNOWN
Trial details
- NCT number
- NCT01732276
- Sponsor
- Jiangmen Central Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.